Content related to Study Leads to Orphan Drug Status for Acute Myeloid Leukemia

Acute lymphoblastic leukemia (ALL) affects about 3,000 children each year in the United States. In one tenth of cases, the cancer resists treatment. Yong-Mi Kim, MD, PhD, MPH investigates just how

Actually, it can hide. CHLA’s Yong-Mi Kim tells us exactly how leukemia burrows within bone marrow, where it is shielded from cancer treatments. But given Kim’s breakthrough research on acute

Yves De Clerck, MD

A fourth-year PhD candidate, Heather is researching the role of integrin beta-1 in pediatric acute myeloid leukemia

5 Questions for Jeri Wilson, Executive Director of the Pediatric Cancer Research Foundation

Risk of detecting cancer cells decreased by 70% after one month of treatment

Samantha is a PhD student exploring a potential therapeutic target in drug-resistant leukemia.